Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,763 | 71,891 | 183,546 | 57,339 | 22,697 |
| Receivables | 106,005 | 103,228 | 112,417 | 103,539 | 85,018 |
| Inventories | 146,928 | 140,240 | 146,103 | 144,535 | 94,387 |
| Income taxes - deferred | 35,284 | 29,972 | 24,135 | 22,254 | 10,010 |
| TOTAL | $444,849 | $365,363 | $497,392 | $339,931 | $221,761 |
| Non-Current Assets | |||||
| PPE Net | 99,456 | 83,526 | 76,003 | 61,730 | 42,559 |
| Intangibles | 456,832 | 473,058 | 438,092 | 403,204 | 342,130 |
| Other Non-Current Assets | 17,996 | 18,155 | 14,527 | 13,147 | 7,168 |
| TOTAL | $574,284 | $574,739 | $528,622 | $478,081 | $391,857 |
| Total Assets | $1,019,133 | $940,102 | $1,026,014 | $818,012 | $613,618 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 76,760 | N/A | 119,962 | 119,542 |
| Accounts payable and accrued liabilities | 27,783 | 24,598 | 22,964 | 23,232 | 20,329 |
| Accrued Expenses | 61,192 | 51,295 | 48,734 | 45,576 | 29,827 |
| TOTAL | $201,857 | $156,730 | $174,751 | $191,671 | $274,017 |
| Non-Current Liabilities | |||||
| Long Term Debt | 139,688 | 160,000 | 160,000 | N/A | N/A |
| Deferred Revenues | 4,444 | 4,077 | 3,053 | 2,901 | 4,319 |
| Other Non-Current Liabilities | 166,980 | 169,168 | 318,954 | 349,860 | 12,083 |
| TOTAL | $317,313 | $338,487 | $478,954 | $365,912 | $43,439 |
| Total Liabilities | $519,170 | $495,217 | $653,705 | $557,583 | $317,456 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,208 | 57,358 | 56,286 | 54,614 | 54,655 |
| Common Shares | 355 | 350 | 344 | 323 | 315 |
| Retained earnings | 232,830 | 167,161 | 116,206 | 98,175 | 66,336 |
| Other shareholders' equity | -1,453 | 8,525 | 4,975 | 18,665 | 8,234 |
| TOTAL | $499,963 | $444,885 | $372,309 | $260,429 | $296,162 |
| Total Liabilities And Equity | $1,019,133 | $940,102 | $1,026,014 | $818,012 | $613,618 |